Here we report imaging studies of a patient with pulmonary benign metastasizing leiomyoma (BML). A 44-year-old woman who underwent a hysterectomy for uterine cellular leiomyoma presented with abnormal shadows on a chest X-ray. Chest computed tomography (CT) revealed multiple well-defined nodules in both lungs. Chest magnetic resonance imaging (MRI) indicated these nodules as T1-low/T2-high intensity lesions. Contrast-enhanced MRI indicated these nodules as well-enhanced lesions, while 18 F-fluorodeoxyglucose positron emission tomography-CT revealed no abnormal accumulation in these nodules. Bilateral lung wedge resections were performed for the largest 2 lesions to confirm the diagnosis, and both nodules were histologically diagnosed as BML.
Introduction
Benign metastasizing leiomyoma (BML) is a rare disease that occurs in patients with benign leiomyomatous lesions, predominantly in women with a previous history of uterine leiomyoma [1] . Surgical resection is usually performed for histological diagnostic and/or curative purposes, while endocrine therapy [2] and a wait-and-see strategy [3] are also common approaches to this disease since the clinical course is typically indolent [4] . Clinically, it is important to distinguish between BML and metastatic leiomyosarcoma (LMS) because the therapeutic strategies and prognoses for BML and LMS are quite different; however, the understanding of typical imaging findings of BML is incomplete.
Case Report
A 44-year-old woman who had undergone a simple hysterectomy for uterine cellular leiomyoma 30 months earlier was found to have asymptomatic multiple pulmonary nodules, according to a chest X-ray. Chest computed tomography (CT) scans showed bilateral multiple pulmonary nodules (Figures 1(a)-(d) ). Chest magnetic resonance imaging (MRI) revealed T1-low intensity/T2-high intensity nodules (Figures 2(a) and ( in the present case appeared as T1-low/T2-high intensity nodules on MRI and as blood flow-rich tumors on contrast-enhanced MRI. A few studies reported 18 F-FDG PET-CT findings in pulmonary BML, and all appeared as avid-mild accumulating nodules [5] [6] [7] [8] . In accordance with previous reports, the lesions in the present case did not take up 18 F-FDG, suggesting that BML is a blood flow-rich tumor with low metabolic activity.
The main clinical interest is to distinguish BML from metastatic LMS. Ogawa and his collaborator reported that pulmonary BML with malignant transformation showed high 18 F-FDG uptake with a maximum SUV of 18.8 [9] , suggesting that 18 F-FDG PET-CT might be a useful tool to distinguish BML from LMS. On the other hand, it was reported that uterine leiomyoma showed 99m Tc uptake [10] and that pulmonary BML showed high 99m Tc uptake but low 18 F-FDG uptake [8] , suggesting that Tc scintigraphy might be a useful diagnostic option to distinguish BML from other diseases.
In conclusion, we experienced a case of BML. The lesions were well enhanced on contrast-enhanced MRI, while no metabolic activity was indicated on 18 F-FDG PET-CT, suggesting that BML is a blood flow-rich tumor with low metabolic activity.
